Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Adenocarcinoma of the Pancreas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00735917
What this trial is testing

Saracatinib in Treating Patients With Previously Treated Metastatic Pancreatic Cancer

Who this might be right for
Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage IV Pancreatic Cancer
National Cancer Institute (NCI) 19
Large-scale testing (Phase 3)UnknownNCT00005869
What this trial is testing

Nitrocamptothecin Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Astex Pharmaceuticals, Inc.
Early research (Phase 1)Ended earlyNCT04807972
What this trial is testing

Study to Evaluate Adverse Events and Change in Disease Activity When Intravenous (IV) Infusion of ABBV-927 is Administered in Combination With IV Modified FOLFIRINOX (mFFX) With or Without IV Budigalimab Compared to mFFX in Adult Participants With Untreated Pancreatic Cancer Metastasis

Who this might be right for
Pancreatic Cancer
AbbVie 40
Not applicableStudy completedNCT06481397
What this trial is testing

OSCAR I STUDY - The ONCObind CTC Removal Study

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)
ExThera Medical Corporation 5
Testing effectiveness (Phase 2)Ended earlyNCT06478862
What this trial is testing

Promitil Treatment of Patients With Solid Tumors Associated With Deleterious Mutations Who Have Progressed After Therapy

Who this might be right for
Cancer of OvaryPancreatic Ductal Adenocarcinoma
Lipomedix Pharmaceuticals Inc. 19
Testing effectiveness (Phase 2)Temporarily pausedNCT05419479
What this trial is testing

Switch Maintenance in Pancreatic

Who this might be right for
Pancreatic CancerAdenocarcinoma of the PancreasSquamous Cell Carcinoma of Pancreas+1 more
James Cleary, MD, PhD 46
Testing effectiveness (Phase 2)Study completedNCT02194829
What this trial is testing

Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Gemcitabine Hydrochloride With or Without WEE1 Inhibitor AZD1775 in Treating Patients With Previously Untreated Pancreatic Cancer That Is Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Metastatic Pancreatic AdenocarcinomaStage III Pancreatic Cancer AJCC v6 and v7Stage IV Pancreatic Cancer AJCC v6 and v7+1 more
National Cancer Institute (NCI) 8
Testing effectiveness (Phase 2)Study completedNCT00001165
What this trial is testing

Combination Chemotherapy in Patients With Zollinger-Ellison Syndrome and Tumors of the Pancreas

Who this might be right for
Islet Cell AdenomaNeoplasm MetastasisZollinger Ellison Syndrome
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 999
Testing effectiveness (Phase 2)Study completedNCT01204372
What this trial is testing

Trial Evaluating Combined Chemotherapy in Patients With Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Metastatic Pancreatic Adenocarcinoma
Institut du Cancer de Montpellier - Val d'Aurelle 63
Testing effectiveness (Phase 2)Study completedNCT03529175
What this trial is testing

Scheduling Nab-paclitaxel With Gemcitabine

Who this might be right for
Pancreatic Adenocarcinoma Metastatic
CCTU- Cancer Theme 146
Testing effectiveness (Phase 2)Looking for participantsNCT06051695
What this trial is testing

Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

Who this might be right for
Solid Tumor, AdultColorectal CancerNSCLC+17 more
A2 Biotherapeutics Inc. 474
Testing effectiveness (Phase 2)Ended earlyNCT00066677
What this trial is testing

Bevacizumab With or Without Docetaxel in Treating Patients With Previously Treated Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Fox Chase Cancer Center 32
Not applicableUnknownNCT02451384
What this trial is testing

According CTC to Compare the Influences of Different Methods to Remove the PDAC

Who this might be right for
Carcinoma, Pancreatic DuctalCirculating Tumor Cells
Shanghai Zhongshan Hospital 45
Testing effectiveness (Phase 2)Study completedNCT01666730
What this trial is testing

Metformin Plus Modified FOLFOX 6 in Metastatic Pancreatic Cancer

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic Cancer+1 more
Case Comprehensive Cancer Center 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07665684
What this trial is testing

Samuraciclib in Combination With Gemcitabine/Nab-Paclitaxel in Patients With Metastatic Basal-Like Pancreatic Cancer

Who this might be right for
Pancreas Ductal AdenocarcinomaPancreas Cancer, MetastaticPancreatic Adenocarcinoma Metastatic+2 more
University Health Network, Toronto 67
Testing effectiveness (Phase 2)Looking for participantsNCT05086692
What this trial is testing

A Beta-only IL-2 ImmunoTherapY Study

Who this might be right for
Advanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more
Medicenna Therapeutics, Inc. 115
Early research (Phase 1)Ended earlyNCT01654861
What this trial is testing

Safety & Efficacy Study of Gemcitabine...With High Dose IV Vit. C (HDIVC)

Who this might be right for
Metastatic Adenocarcinoma of the Pancreas
Eastern Regional Medical Center 3
Not applicableActive Not RecruitingNCT04002479
What this trial is testing

Alpha Radiation Emitters Device for the Treatment of Advanced Pancreatic Cancer

Who this might be right for
Pancreatic CancerUnresectable Pancreatic CancerMetastatic Pancreatic Cancer+1 more
Alpha Tau Medical LTD. 37
Testing effectiveness (Phase 2)Study completedNCT02004262
What this trial is testing

Safety and Efficacy of Combination Listeria/GVAX Pancreas Vaccine in the Pancreatic Cancer Setting

Who this might be right for
2nd-line, 3rd-line and Greater Metastatic Pancreatic Cancer
Aduro Biotech, Inc. 303
Large-scale testing (Phase 3)Ended earlyNCT00662688
What this trial is testing

Chemotherapy With or Without Dalteparin in Treating Patients With Metastatic Pancreatic Cancer

Who this might be right for
Chemotherapeutic Agent ToxicityPancreatic CancerThromboembolism
GERCOR - Multidisciplinary Oncology Cooperative Group 42
Next Page